Does Mounjaro Cause Constipation?
Mounjaro (tirzepatide), a GLP-1/GIP receptor agonist for type 2 diabetes and weight loss, lists constipation as a common gastrointestinal side effect. Clinical trials showed it in 6-7% of patients, typically mild and occurring early in treatment.[1][2] It's less frequent than nausea (up to 20%) or diarrhea (12-13%), but users report it alongside slowed stomach emptying.[3]
How Common Is Constipation on Mounjaro?
In SURMOUNT-1 (weight loss trial, n=2,539), constipation affected 6.3% on 5mg, 6.8% on 10mg, and 7.1% on 15mg doses versus 1% on placebo. SURPASS trials for diabetes reported similar rates (5-12% across doses).[1][4] Real-world data from patient forums and apps like Drugs.com echoes this, with 5-10% of reviews mentioning it.[5]
Why Does Mounjaro Slow Digestion Leading to Constipation?
Tirzepatide delays gastric emptying, reducing gut motility to promote fullness and weight loss. This mechanism, shared with drugs like Ozempic, can harden stools or reduce bowel frequency. Higher doses (10-15mg) correlate with more cases; it often resolves in 4-8 weeks as the body adjusts.[2][3]
How Long Does Constipation Last and What Helps?
Most cases are transient, peaking in weeks 1-4 and fading by week 12. Management includes:
- Hydration (2-3L water daily) and fiber (25-30g from fruits/veggies).
- Laxatives like MiraLAX or stool softeners (e.g., docusate), but consult a doctor.
- Dose titration: Starting low (2.5mg) minimizes risk.[2][6] Severe or persistent cases warrant medical review for dehydration or impaction.
Compared to Ozempic, Wegovy, or Zepbound
| Drug | Constipation Rate | Notes |
|------|-------------------|-------|
| Mounjaro (tirzepatide) | 6-12% | Dual agonist; similar to single GLP-1s but slightly higher GI effects. |
| Ozempic/Wegovy (semaglutide) | 5-7% | Often less constipation, more nausea/diarrhea. |
| Zepbound (tirzepatide, weight loss brand) | 6-7% | Identical to Mounjaro; same molecule.[1][4] |
Patients switching from semaglutide report comparable or slightly worse constipation on Mounjaro due to GIP action.[3]
When to Worry About Constipation on Mounjaro
Rarely (<1%), it signals ileus (bowel obstruction) or pancreatitis—stop and seek ER if accompanied by vomiting, severe pain, or no bowel movement for 3+ days. Those with prior GI issues (e.g., IBS) face higher risk; monitor closely.[2][6] No link to long-term colon issues in trials up to 72 weeks.
[1]: Mounjaro Prescribing Information (FDA)
[2]: Eli Lilly SURMOUNT-1 Trial Data (NEJM)
[3]: Drugs.com Mounjaro Side Effects
[4]: SURPASS Trials Summary (Lancet)
[5]: WebMD User Reviews
[6]: Mayo Clinic GLP-1 Side Effect Management